Conformis to be Acquired by restor3d

restor3d and Conformis entered into a definitive merger agreement under which restor3d will acquire all outstanding shares of common stock of Conformis at $2.27 per share in cash, which represents an approximate 96% premium to the closing price of Conformis stock on June 22, 2023.

The pandemic hit Conformis especially hard. The company’s...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us